We invite you to attend this virtual educational workshop. Our speakers will discuss state-of-the-art Hemostasis treatments, the role of the Hemostasis Laboratory, and how this can impact patient management care. Hemophilia, Thrombotic Thrombocytopenic Purpura (TTP), and the use of Direct Oral Anticoagulants (DOACs) will be discussed.

Session Overview

• Hemophilia: Evolution of hemophilia therapies and testing technologies used to aid in the diagnosis and monitoring of hemophilia patients
• TTP: Current and new therapies and treatment strategies, laboratory testing, and the impact on patient care
• DOACs: The role of this therapeutic category and the role of laboratory testing in ensuring quality patient care

Dates & Times

October 22, 2024 | 10:00 AM - 12:00 PM EDT
October 23, 2024 | 5:00 AM - 7:00 AM EDT

To accommodate time zones around the world, this program is offered at multiple times, in English and French. When registering, please select the time that best accommodates your schedule.

Objectives

• Hemophilia
  • Detail the evolution of hemophilia A and B treatments
  • Review of hemophilia therapies, and types of testing technologies used
  • Explain the role of the hemostasis laboratory in the diagnosis and monitoring of hemophilia A and B patients
• TTP
  • Provide an overview of current and new TTP therapies and treatment strategies
  • Understand how ADAMTS13 testing is used in patient diagnosis and management
  • Obtain insight into how the results of ADAMTS13 testing play a role in the patient care
• DOACs
  • Review when DOACs are used in patient treatment
  • Discuss the critical role of laboratory testing in DOAC therapy for quality patient care
  • Describe how the accurate measurement of DOAC levels in the laboratory affects patient management and care
  • Review DOACs in clinical practice, and guidelines for testing to improve patient management

Speakers

Prof. Paul Coppo
Professor of Hematology; Department of Hematology and Reference Center for Thrombotic Microangiopathies, AP-HP and Sorbonne University, Paris, France

​

Dr. Michelle Sholzberg
Division Head, Division of Hematology/Oncology and Medical Director, Coagulation Laboratory, Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada

 ​

Dr. Alberto Tosetto
Head of Hematology at S. Bortolo Hospital in Vicenza, Italy